TY - JOUR
T1 - Pediatric cancer screening in hereditary gastrointestinal cancer risk syndromes
T2 - An update from the AACR Childhood Cancer Predisposition Working Group
AU - MacFarland, Suzanne P
AU - Becktell, Kerri
AU - Schneider, Kami Wolfe
AU - Kuiper, Roland P
AU - Lesmana, Harry
AU - Meade, Julia
AU - Nichols, Kim E
AU - Porter, Christopher C
AU - Savage, Sharon A
AU - Schultz, Kris Ann
AU - Scott, Hamish
AU - States, Lisa
AU - Tabori, Uri
AU - Tamura, Chieko
AU - Tomlinson, Gail
AU - Zelley, Kristin
AU - Durno, Carol
AU - Bauer, Andrew
AU - Plon, Sharon E
N1 - ©2024 American Association for Cancer Research.
PY - 2024/10/15
Y1 - 2024/10/15
N2 - Gastrointestinal (GI) polyposis and cancer in pediatric patients is frequently due to an underlying hereditary cancer risk syndrome requiring ongoing cancer screening. Identification of at-risk patients through family history, clinical features of a syndrome, or symptom onset ensures appropriate cancer risk assessment and management in childhood and beyond. In this 2024 perspective, we outline updates to the hereditary GI cancer screening guidelines first published by the American Association of Cancer Research Pediatric Cancer Predisposition Workshop in 2017. These guidelines consider existing recommendations by pediatric and adult gastroenterology consortia to ensure alignment with gastroenterology practices in managing polyposis conditions. We specifically address the recommendations for pediatric screening in familial adenomatous polyposis, Peutz-Jeghers syndrome, and juvenile polyposis syndrome. Further, we emphasize the importance of multidisciplinary care and partnership with gastroenterology, as it is crucial in management of children and families with these conditions.
AB - Gastrointestinal (GI) polyposis and cancer in pediatric patients is frequently due to an underlying hereditary cancer risk syndrome requiring ongoing cancer screening. Identification of at-risk patients through family history, clinical features of a syndrome, or symptom onset ensures appropriate cancer risk assessment and management in childhood and beyond. In this 2024 perspective, we outline updates to the hereditary GI cancer screening guidelines first published by the American Association of Cancer Research Pediatric Cancer Predisposition Workshop in 2017. These guidelines consider existing recommendations by pediatric and adult gastroenterology consortia to ensure alignment with gastroenterology practices in managing polyposis conditions. We specifically address the recommendations for pediatric screening in familial adenomatous polyposis, Peutz-Jeghers syndrome, and juvenile polyposis syndrome. Further, we emphasize the importance of multidisciplinary care and partnership with gastroenterology, as it is crucial in management of children and families with these conditions.
KW - Adenomatous Polyposis Coli/genetics
KW - Child
KW - Early Detection of Cancer/methods
KW - Gastrointestinal Neoplasms/genetics
KW - Genetic Predisposition to Disease
KW - Genetic Testing/methods
KW - Humans
KW - Neoplastic Syndromes, Hereditary/genetics
KW - Peutz-Jeghers Syndrome/genetics
KW - Practice Guidelines as Topic
KW - Risk Assessment/methods
KW - Gastrointestinal Neoplasms/diagnosis
UR - https://www.mendeley.com/catalogue/a5750d12-7fc5-3790-b72d-8f538b31c196/
U2 - 10.1158/1078-0432.CCR-24-0953
DO - 10.1158/1078-0432.CCR-24-0953
M3 - Article
C2 - 39190470
SN - 1078-0432
VL - 30
SP - 4566
EP - 4571
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 20
ER -